Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer

Head and Neck

Volumn 30, Issue 7, 2008, Pages 852-857

  Chang, Ah Ram ^a   Wu, Hong Gyun ^a   Park, Charn Il ^a   Jeon, Yoon Kyung ^a   Kim, Chul Woo ^a  

^a Seoul National University   (South Korea)

Author keywords

Cyclin D1; EGFR; Glottic cancer; Immunohistochemistry; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; BIOPSY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROL GROUP; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYCLIN D1; EARLY DIAGNOSIS; EPIDERMAL GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 47549111192     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20788     Document Type: Article

References (23)

1. Cattaruzza MS, Maisonneuve P, Boyle P, et al. Epidemiology of laryngeal cancer. Oral Oncol 1996;32:293-305.
2. Goldsimth M, Pillsbury HC. Pathologic and cytometric indicators of biologic behavior in laryngeal cancer. In: Silver CE, editor. Laryngeal cancer. New York: Thieme Medical Publisher; 1991. pp 27-32.
3. Mendelsohn J, Basega J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 2003;21:2187-2199.
4. Liang K, Ang KK, Milas L, Hunter N, Fan Z. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 2003;57:246-254.
5. Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy. Int J Radiat Oncol Biol Phys 2004;49:427-433.
6. Jares P, Fernandea PL, Campo E, et al. PRAD-1/cyclin Dlgene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinoma. Cancer Res 1994;54:4813-4817.
7. Barkova J, Lukas J, Straus J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775-778.
8. Barkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-361.
9. Michalides R, Veelen N, Hart A, et al. Overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1995;73:728-734.
10. Muller D, Millon R, Lindereau R, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinoma. Oral Oncol 1994;30:113-120.
11. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-2 glottic carcinoma. Cancer 2004;100:1786-1792.
12. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Eng J Med 2006;354:567-578.
13. Vlachtsis K, Nikolaou A, Markou K, Fountzilas G, Daniilidis I. Clinical and molecular prognostic factors in operable laryngeal cancer. Head Neck Oncol 2005;405:916-623.
14. Almadori G, Cadoni G, Galli J, et al. Epidermal growth factor receptor expression in primary laryngeal cancer. Int J Cancer 1999;84:188-191.
15. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003;260:502-508.
16. Maurizi M, Almadori G, Ferrandia G, et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996;74:1253-1257.
17. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001;1:222-231.
18. Peters G, Fantl V, Smith R, et al. Chromosome 11q13markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 1995;33:125-135.
19. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-671.
20. Milas L, Akimoto T, Hunter NR, et al. Relationship between cyclin D1 expression and poor radioresponse of murine carcinoma. Int J Radiat Oncol Biol Phys 2002; 52:514-521.
21. Raffety MA, Fenton JE, Jones AS. An overview of the role and inter relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. Clin Otolaryngol 2001;26:317-320.
22. Bellacosa A, Almadori G, Cavallo S, et al. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas. Clin Cancer Res 1996;2:175-180.
23. Akimoto T, Hunter NR, Buchmiller L, Mason K, Ang K, Milas L. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinoma. Clin Cancer Res 1999;5:2884-2890.